Lannett Company has received approval from the U.S. Food and Drug Administration of its Abbreviated New Drug Application for Phentermine Hydrochloride Blue/White Seed Capsules USP, 30 mg, the generic equivalent of Sandoz, Inc.s Reference Listed Drug Phentermine Hydrochloride Capsules USP, 30 mg. The company intends to launch this new product in the current first quarter of fiscal 2011.
@TheLazyDeath how did they work?
bryjb10 2 days ago
I'm taking that, we'll see if it works. i'm on Day 2, wish me luck >.<
TheLazyDeath 9 months ago
Yeah!!! I work for them!!!
ionthegravity 1 year ago